Document is current
Any future updates will be listed below
-
Authors
Chen, BaoQing https://orcid.org/0000-0001-9807-7425
Chen, Junying https://orcid.org/0000-0001-7732-4319
Wang, Sifen
Bai, Kunhao
Li, Zimeng
Chen, Biqi https://orcid.org/0009-0000-9388-2820
Wang, Ruixi
Cheng, Xingyuan
Gao, Yilu
Yi, Chen
Cen, Peiying
Li, Shuangjiang
Dragomir, Mihnea P
Zhu, Yujia
Li, Qiaoqiao https://orcid.org/0000-0002-6299-4966
Yang, Hong https://orcid.org/0000-0002-6007-9086
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05520619 at ClinicalTrials.govnct05520619 at ClinicalTrials.govDocuments that mention this clinical trial
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)
https://doi.org/10.1200/jco-25-03044
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials
https://doi.org/10.1136/jitc-2025-013065
Documents that mention this clinical trial
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)
https://doi.org/10.1200/jco-25-03044
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trials
https://doi.org/10.1136/jitc-2025-013065
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82172669)
National Natural Science Foundation of China (82373214)
National Natural Science Foundation of China (82473241)
Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515010951)
Basic and Applied Basic Research Foundation of Guangdong Province (2025B1515020090)
Berlin Institute of Health, Clinician Scientist Program, and DKTK Berlin Young Investigator Grant (2022)
Young Talents Program of Sun Yat-sen University Cancer Center (PT22121101 and PT22121201)
Chinese Institute of Food Science and Technology (CIFST) - Abbott Foundation of Food Nutrition and Safety (No. 2020-13)
- License Information
